Status:
COMPLETED
Bone Mineral Density and Vascular Calcifications in the Population of Lithiasis Patients With Idiopathic Hypercalciuria
Lead Sponsor:
Agnieszka Pozdzik
Conditions:
Hypercalciuria; Idiopathic
Eligibility:
All Genders
18+ years
Brief Summary
In industrialized countries, it is estimated that around 10% of the population suffers from nephrolithiasis (NL). Numerous recent epidemiological studies report that the prevalence and incidence of NL...
Eligibility Criteria
Inclusion
- Diagnosis of recurrent NL confirmed by URO CT with presence of idiopathic hypercalciuria and metabolic workup available.
Exclusion
- People with stones other than calcium (uric acid, cysteine, infectious stones, indinavir stones, primary hyperoxaluria) or with secondary hypercalciuria (primary hyperparathyroidism, sarcoidosis).
Key Trial Info
Start Date :
January 12 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 21 2022
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04770506
Start Date
January 12 2021
End Date
June 21 2022
Last Update
February 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Brugmann
Brussels, Belgium, 1020